Insider trading

Period: 120 months Stock: PHR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

437 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

437 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

437 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

437 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
437 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
437 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

437 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
8 Jan 2025
Roberts Evan Chief Operating Officer
Sold on a plan 2×
$74.94K 2,681 at 27.95
0.3%
Planned (10b5-1)
8 Jan 2025
Hui Yvonne Principal Accounting Officer
Sold on a plan
$8.06K 288 at 28.00
1.1%
Planned (10b5-1)
7 Jan 2025
Roberts Evan Chief Operating Officer
Sold on a plan
$197.61K 7,319 at 27.00
0.9%
Planned (10b5-1)
6 Jan 2025
Indig Chaim Chief Executive Officer
Sold at will
$143.00K 5,375 at 26.61
0.4%
Not planned
6 Jan 2025
Hoffman Allison C General Counsel & Secretary
Sold at will
$105.94K 3,982 at 26.61
2.4%
Not planned
6 Jan 2025
Gandhi Balaji Chief Financial Officer
Sold at will
$85.00K 3,195 at 26.61
2.1%
Not planned
6 Jan 2025
Linetsky David SVP, Life Sciences
Sold at will
$83.36K 3,133 at 26.61
1.3%
Not planned
6 Jan 2025
Roberts Evan Chief Operating Officer
Sold on a plan
$76.44K 2,873 at 26.61
0.4%
Planned (10b5-1)
6 Jan 2025
VanDuyn Amy Beth SVP, Human Resources
Sold at will
$34.88K 1,311 at 26.61
1.1%
Not planned
18 Dec 2024
Hoffman Allison C General Counsel & Secretary
Sold on a plan
$86.96K 3,495 at 24.88
2.9%
Planned (10b5-1)
18 Dec 2024
Linetsky David SVP, Life Sciences · indirect
Sold at will
$609.02 24 at 25.38
0.3%
Not planned
17 Dec 2024
Linetsky David SVP, Life Sciences · indirect
Sold at will 2×
$1.53K 61 at 25.06
0.7%
Not planned
16 Dec 2024
Sold on a plan
$21.75K 861 at 25.26
0.4%
Planned (10b5-1)
16 Dec 2024
Linetsky David SVP, Life Sciences · indirect
Sold at will
$870.89 35 at 24.88
0.4%
Not planned
13 Dec 2024
Sold on a plan
$515.04K 20,565 at 25.04
7.8%
Planned (10b5-1)
11 Dec 2024
Sold on a plan
$466.19K 18,574 at 25.10
7.1%
Planned (10b5-1)
11 Dec 2024
Linetsky David SVP, Life Sciences
Sold on a plan
$294.56K 11,853 at 24.85
5.9%
Planned (10b5-1)
10 Dec 2024
Roberts Evan Chief Operating Officer
Sold on a plan
$602.16K 25,000 at 24.09
3.3%
Planned (10b5-1)
3 Dec 2024
VanDuyn Amy Beth SVP, Human Resources
Sold on a plan
$532.56K 25,447 at 20.93
21.4%
Planned (10b5-1)
2 Dec 2024
Sold on a plan
$318.37K 15,152 at 21.01
5.9%
Planned (10b5-1)
18 Oct 2024
Linetsky David SVP, Life Sciences
Sold on a plan
$22.54K 1,100 at 20.49
0.5%
Planned (10b5-1)
16 Oct 2024
Hui Yvonne Principal Accounting Officer
Sold on a plan
$9.02K 423 at 21.33
1.6%
Planned (10b5-1)
15 Oct 2024
Indig Chaim Chief Executive Officer
Sold at will
$64.95K 3,089 at 21.03
0.3%
Not planned
15 Oct 2024
Hui Yvonne Principal Accounting Officer
Sold on a plan 2×
$58.40K 2,791 at 20.92
9.3%
Planned (10b5-1)
15 Oct 2024
Linetsky David SVP, Life Sciences
Sold at will
$42.28K 2,011 at 21.03
1.0%
Not planned
15 Oct 2024
Roberts Evan Chief Operating Officer
Sold at will
$38.75K 1,843 at 21.03
0.2%
Not planned
15 Oct 2024
Hoffman Allison C General Counsel & Secretary
Sold at will
$25.48K 1,212 at 21.03
1.0%
Not planned
15 Oct 2024
Gandhi Balaji Chief Financial Officer
Sold at will
$18.17K 864 at 21.03
0.9%
Not planned
15 Oct 2024
VanDuyn Amy Beth SVP, Human Resources
Sold at will
$13.12K 624 at 21.03
0.5%
Not planned
19 Sep 2024
Linetsky David SVP, Life Sciences · indirect
Sold at will
$577.04 24 at 24.04
0.3%
Not planned
18 Sep 2024
Linetsky David SVP, Life Sciences · indirect
Sold at will
$1.47K 61 at 24.09
0.7%
Not planned
17 Sep 2024
Linetsky David SVP, Life Sciences · indirect
Sold at will
$891.54 36 at 24.77
0.4%
Not planned
12 Sep 2024
Sold at will
$32.24K 1,400 at 23.03
7.2%
Not planned
11 Sep 2024
Hoffman Allison C General Counsel & Secretary
Sold on a plan
$48.40K 2,072 at 23.36
1.7%
Planned (10b5-1)
10 Sep 2024
Indig Chaim Chief Executive Officer
Sold at will
$123.11K 5,295 at 23.25
0.4%
Not planned
10 Sep 2024
Gandhi Balaji Chief Financial Officer
Sold at will
$81.42K 3,502 at 23.25
3.4%
Not planned
10 Sep 2024
Roberts Evan Chief Operating Officer
Sold at will
$73.19K 3,148 at 23.25
0.4%
Not planned
10 Sep 2024
Hoffman Allison C General Counsel & Secretary
Sold on a plan
$60.96K 2,622 at 23.25
2.1%
Planned (10b5-1)
10 Sep 2024
Linetsky David SVP, Life Sciences
Sold at will
$39.90K 1,716 at 23.25
0.8%
Not planned
10 Sep 2024
Hui Yvonne Principal Accounting Officer
Sold at will
$17.30K 744 at 23.25
2.4%
Not planned
10 Sep 2024
VanDuyn Amy Beth SVP, Human Resources
Sold at will
$17.14K 737 at 23.25
0.6%
Not planned
10 Sep 2024
Linetsky David SVP, Life Sciences · indirect
Sold at will
$2.21K 95 at 23.25
1.0%
Not planned
26 Aug 2024
Hoffman Allison C General Counsel & Secretary
Sold at will
$367.24K 14,110 at 26.03
10.4%
Not planned
29 Jul 2024
Indig Chaim Chief Executive Officer
Sold on a plan
$173.25 7 at 24.75
0.0%
Planned (10b5-1)
18 Jul 2024
Sold on a plan
$175.00K 7,000 at 25.00
18.6%
Planned (10b5-1)
16 Jul 2024
Indig Chaim Chief Executive Officer
Sold at will
$62.76K 2,644 at 23.74
0.2%
Not planned
16 Jul 2024
Linetsky David SVP, Life Sciences
Sold at will
$43.20K 1,820 at 23.74
0.9%
Not planned
16 Jul 2024
Roberts Evan Chief Operating Officer
Sold at will
$39.61K 1,669 at 23.74
0.2%
Not planned
16 Jul 2024
Hoffman Allison C General Counsel & Secretary
Sold at will
$18.99K 800 at 23.74
0.6%
Not planned
16 Jul 2024
Gandhi Balaji Chief Financial Officer
Sold at will
$18.58K 783 at 23.74
0.8%
Not planned
Showing 151–200 of 437. ← Newer Page 4 of 9 Older →